You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Improved Ultrafilters for Bioprocessing
SBC: Abel Company Topic: N/AEfficient separation and purification of bioproducts on a commercial scale are controlling steps in the bioprocessing of high value-added products such as therapeutics in human health care. This project will examine the feasibility of achieving significant improvement in downstream processing through-put by the use of flow-induced vortices to reduce or eliminate the effect of concentration polariz ...
SBIR Phase I 1993 Department of Health and Human Services -
HEART RATE VARIABILITY ANALYSIS USING POLYNOMIAL NETWORK
SBC: ABTECH CORPORATION Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
LONG RANGE POPULATION PROJECTION BY DISABILITY STATUS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
LONG-TERM CARE INSURANCE: A MANUAL FOR REGULATORS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1990 Department of Health and Human Services -
PSO ACTUARIAL RATE MODEL FOR MEDICARE RISK CONTRACTS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
NOVEL ADENOSINE A2A AGONISTS IN RENAL TISSUE PROTECTION
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/ADESCRIPTION (provided by applicant): The development of new treatments for the effective reduction of renal injury associated with acute renal failure and kidney transplantation will have a great impact on health care delivery to patients with renal disease. Acute ischemic renal failure affects 5 percent of hospitalized patients and has a mortality rate approaching 50 percent. At present, dialysis ...
SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
A2A ADENOSINE AGONISTS AS NEUROPROTECTANTS
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/ADESCRIPTION (provided by applicant): The central goal of this research is to develop a new drug to prevent spinal cord reperfusion injury secondary to aortic clamping that occurs frequently during thoracic surgery. Irreversible spinal cord injury resulting in paraplegia or paraparesis is the single most devastating complication of surgery on the thoracic and thor ...
SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
ADVANCED DIABETES MANAGEMENT SYSTEM
SBC: Adherence Technologies Corp. Topic: N/ADESCRIPTION (provided by applicant): For the 10 million people in the U.S. with Type 2 diabetes, it is essential to follow strict regimens that include diet, weight, exercise, eye care and foot care. The prescribed regimen promotes glycemic control, which is correlated with better health. Many have proposed interventions that are either time/labor intensive and costly (regular phone calls from nu ...
SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
ACCUNURSE SYSTEM
SBC: Adherence Technologies Corp. Topic: N/ADESCRIPTION (provided by applicant): The AccuNurse System has been successfully developed in Phase I to provide an easy-to-use "mentor" and communications tool for CNAs and nurses in skilled nursing units. Wireless and advanced speech technologies are merged into a conversational system that provides: individualized resident information, paperless documentation at the point of care, and many other ...
SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
SMALL MOLECULE BLOCKERS OF B. ANTHRACIS TOXIN
SBC: Innovative Biologics Inc. Topic: N/ADESCRIPTION (provided by applicant): The overall goal of this SBIR proposal is the identification of small molecules capable of blocking the cytotoxic action of Bacillus anthracis lethal toxin by blocking the transmembrane pore formed by the protective antigen component of the toxin. Such molecules are envisioned for use as drugs for the treatment of anthrax. The strategy to identify such compoun ...
SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health